CLDN1 and autoimmune thyroid disease: Among the potential targets (Fig. 4a), we focused on CLDN1 because it was downregulated in the thyrocytes after infection with LV-has-mir-142 using qRT-PCR (Fig. 4b) and was lost in various autoimmune diseases, including autoimmune thyroid disease [16, 17].